Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1405
Publisher
MDPI AG
Online
2019-09-20
DOI
10.3390/cancers11101405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
- (2019) Yu Yin et al. Molecular Cancer
- ONECUT2 is a driver of neuroendocrine prostate cancer
- (2019) Haiyang Guo et al. Nature Communications
- Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response
- (2019) Javian Malcolm et al. Cancers
- T-type Calcium Channels in Cancer
- (2019) Lauren Antal et al. Cancers
- Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
- (2019) Loredana Puca et al. Science Translational Medicine
- Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment
- (2019) Wanfu Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The influence of treatment sequence in the prognostic value of TMPRSS2‐ERG as biomarker of taxane resistance in castration‐resistant prostate cancer
- (2019) Mercedes Marín‐Aguilera et al. INTERNATIONAL JOURNAL OF CANCER
- Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer
- (2019) Miguel Reina-Campos et al. CANCER CELL
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of lineage plasticity in prostate cancer therapy resistance
- (2019) Himisha Beltran et al. CLINICAL CANCER RESEARCH
- Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
- (2019) H.J. Boyle et al. EUROPEAN JOURNAL OF CANCER
- PEG10 is associated with treatment-induced neuroendocrine prostate cancer
- (2019) Soojin Kim et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes
- (2019) Elizabeth J. Adams et al. NATURE
- T‐type calcium channels drive the proliferation of androgen‐receptor negative prostate cancer cells
- (2019) Roberto Silvestri et al. PROSTATE
- N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
- (2019) Adeline Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen deprivation therapy-induced epithelial-mesenchymal transition of prostate cancer through downregulating SPDEF and activating CCL2
- (2018) Yuan-Chin Tsai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration
- (2018) Qiuli Liu et al. CLINICAL CANCER RESEARCH
- Phase 1 Study of Seviteronel, a Selective CYP17 Lyase and Androgen Receptor Inhibitor, in Men with Castration-Resistant Prostate Cancer
- (2018) Shilpa Gupta et al. CLINICAL CANCER RESEARCH
- Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
- (2018) Philipp Nuhn et al. EUROPEAN UROLOGY
- Clinical and molecular features of treatment-related neuroendocrine prostate cancer
- (2018) Shusuke Akamatsu et al. INTERNATIONAL JOURNAL OF UROLOGY
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
- (2018) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer
- (2018) John K. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epigenetic reprogramming: A key mechanism driving therapeutic resistance
- (2018) Anjali V. Sheahan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies
- (2018) Loredana Puca et al. Cold Spring Harbor Perspectives in Medicine
- Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer
- (2018) Elena Jachetti et al. Cancer Immunology Research
- PD-1/PD-L1 pathway inhibitors in advanced prostate cancer
- (2018) Pedro Isaacsson Velho et al. Expert Review of Clinical Pharmacology
- Results of a prospective phase 2 pilot trial of Lu177 PSMA 617 therapy for metastatic castrate resistant prostate cancer including Imaging predictors of treatment response and patterns of progression.
- (2018) Louise Emmett et al. Clinical Genitourinary Cancer
- Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming
- (2018) Rajeev Mishra et al. JOURNAL OF CLINICAL INVESTIGATION
- Therapy-induced small-cell disease: from mouse to man and back
- (2018) Magdalena M. Grabowska et al. Nature Reviews Urology
- Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
- (2018) Manabu Kato et al. ONCOGENE
- SRRM4 gene expression correlates with neuroendocrine prostate cancer
- (2018) Yinan Li et al. PROSTATE
- Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers
- (2018) Yan Zhang et al. Nature Communications
- Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
- (2018) Amilcar Flores-Morales et al. CLINICAL CANCER RESEARCH
- Dosimetry of Lu-177 PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pre-therapeutic imaging and “whole body” tumor dosimetry with treatment outcomes
- (2018) John A Violet et al. JOURNAL OF NUCLEAR MEDICINE
- ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis
- (2018) Mirja Rotinen et al. NATURE MEDICINE
- Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage
- (2018) Jung Wook Park et al. SCIENCE
- Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
- (2018) Marcello Tucci et al. OncoTargets and Therapy
- Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer
- (2018) Anna C. Ferrari et al. CLINICAL CANCER RESEARCH
- SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
- (2017) Yinan Li et al. EUROPEAN UROLOGY
- Differential impact of RB status on E2F1 reprogramming in human cancer
- (2017) Christopher McNair et al. JOURNAL OF CLINICAL INVESTIGATION
- Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT
- (2017) Alberto Bongiovanni et al. MEDICINE
- FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate
- (2017) Jung Wook Park et al. MODERN PATHOLOGY
- ABCB1 Mediates Cabazitaxel–Docetaxel Cross-Resistance in Advanced Prostate Cancer
- (2017) Alan P. Lombard et al. MOLECULAR CANCER THERAPEUTICS
- Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth
- (2017) Jacob Kach et al. MOLECULAR CANCER THERAPEUTICS
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Biology and evolution of poorly differentiated neuroendocrine tumors
- (2017) David S Rickman et al. NATURE MEDICINE
- FOXA1 inhibits prostate cancer neuroendocrine differentiation
- (2017) J Kim et al. ONCOGENE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
- (2017) Sheng Yu Ku et al. SCIENCE
- Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications
- (2017) Shalini S. Yadav et al. Translational Oncology
- Neuroendokrines Prostatakarzinom
- (2017) S. Tritschler et al. UROLOGE
- Neuroendokrines Prostatakarzinom
- (2017) S. Tritschler et al. UROLOGE
- Emerging Variants of Castration-Resistant Prostate Cancer
- (2017) Panagiotis J. Vlachostergios et al. Current Oncology Reports
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- Modulation of cabozantinib efficacy by the prostate tumor microenvironment
- (2017) Manisha Tripathi et al. Oncotarget
- Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
- (2017) Neel Shah et al. eLife
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Neuroendocrine differentiation in prostate cancer: key epigenetic players
- (2017) Karishma Gupta et al. Translational Cancer Research
- c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks
- (2017) Stefan J. Barfeld et al. EBioMedicine
- Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance
- (2017) Daniel Crona et al. Cancers
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
- (2016) Etienne Dardenne et al. CANCER CELL
- N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
- (2016) John K. Lee et al. CANCER CELL
- Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
- (2016) S. You et al. CANCER RESEARCH
- Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617
- (2016) Carl Diedrich Schlenkhoff et al. CLINICAL NUCLEAR MEDICINE
- Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β
- (2016) Elena Jachetti et al. MOLECULAR CANCER THERAPEUTICS
- Triiodothyronine Attenuates Prostate Cancer Progression Mediated by β-Adrenergic Stimulation
- (2016) Evangelina Delgado-González et al. MOLECULAR MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
- (2016) K E Richards et al. ONCOGENE
- The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer
- (2016) Francesco Crea et al. Epigenomics
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells
- (2016) Meixiang Sang et al. Oncotarget
- The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
- (2015) H. Beltran et al. CLINICAL CANCER RESEARCH
- Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer
- (2015) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas
- (2015) H. Tsai et al. CLINICAL CANCER RESEARCH
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5
- (2015) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
- (2015) Fred Saad et al. LANCET ONCOLOGY
- Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals
- (2015) Qiang Dang et al. Molecular Oncology
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
- (2015) Bruno Costa-Silva et al. NATURE CELL BIOLOGY
- Transforming growth factor-β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells
- (2015) Fayth L. Miles et al. PROSTATE
- Metformin and prostate cancer stem cells: a novel therapeutic target
- (2015) M J Mayer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals
- (2015) Hongjun Xie et al. Oncotarget
- SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer
- (2015) Murali Gururajan et al. Oncotarget
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Polycomb-mediated silencing in neuroendocrine prostate cancer
- (2015) Pier-Luc Clermont et al. Clinical Epigenetics
- Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
- (2015) Chang-Deng Hu et al. Frontiers in Oncology
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
- (2015) Juan Miguel Mosquera et al. NEOPLASIA
- Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
- (2014) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
- (2014) Jiaoti Huang et al. ASIAN JOURNAL OF ANDROLOGY
- Mouse models of prostate cancer: picking the best model for the question
- (2014) Magdalena M. Grabowska et al. CANCER AND METASTASIS REVIEWS
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- Aggressive Variants of Castration-Resistant Prostate Cancer
- (2014) H. Beltran et al. CLINICAL CANCER RESEARCH
- Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells
- (2014) Maïté Courel et al. EUROPEAN JOURNAL OF CANCER
- Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
- (2014) Hai Tao Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype
- (2014) David J DeGraff et al. LABORATORY INVESTIGATION
- TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation
- (2014) Z Mounir et al. ONCOGENE
- Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression
- (2014) R Jin et al. ONCOGENE
- Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells
- (2014) Pei-Ching Chang et al. PLoS One
- Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
- (2014) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SOX2 expression in the developing, adult, as well as, diseased prostate
- (2014) X Yu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review
- (2014) P Sargos et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program
- (2014) Hong-Jian Jin et al. Nature Communications
- Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention
- (2014) Mannan Nouri et al. Frontiers in Oncology
- The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
- (2014) Stéphane Terry et al. Frontiers in Oncology
- Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
- (2013) Markus Brockmann et al. CANCER CELL
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Radium-223 Chloride: Extending Life in Prostate Cancer Patients by Treating Bone Metastases
- (2013) M. D. Wissing et al. CLINICAL CANCER RESEARCH
- Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
- (2013) A. M. Aparicio et al. CLINICAL CANCER RESEARCH
- Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
- (2013) H.-L. Tan et al. CLINICAL CANCER RESEARCH
- Hypoxia, notch signalling and prostate cancer
- (2013) Laure Marignol et al. Nature Reviews Urology
- REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
- (2013) C. Svensson et al. NUCLEIC ACIDS RESEARCH
- Human ASH-1 Promotes Neuroendocrine Differentiation in Androgen Deprivation Conditions and Interferes With Androgen Responsiveness in Prostate Cancer Cells
- (2013) Ida Rapa et al. PROSTATE
- Interleukin-6
- (2012) Nikki A. Delk et al. Autophagy
- The Dark Side of Mast Cell-Targeted Therapy in Prostate Cancer
- (2012) P. Pittoni et al. CANCER RESEARCH
- The reactive stroma microenvironment and prostate cancer progression
- (2012) David A Barron et al. ENDOCRINE-RELATED CANCER
- Small cell–like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases
- (2012) Stephen Lee et al. HUMAN PATHOLOGY
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- p21-Activated kinase 4 promotes prostate cancer progression through CREB
- (2012) M-H Park et al. ONCOGENE
- Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2
- (2012) Aparna Gupta et al. PROSTATE
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
- (2011) A. Flechon et al. ANNALS OF ONCOLOGY
- Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers
- (2011) P. Pittoni et al. CANCER RESEARCH
- ERG gene rearrangements are common in prostatic small cell carcinomas
- (2011) Tamara L Lotan et al. MODERN PATHOLOGY
- Notch Signaling Modulates Hypoxia-Induced Neuroendocrine Differentiation of Human Prostate Cancer Cells
- (2011) G. Danza et al. MOLECULAR CANCER RESEARCH
- LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling
- (2011) Dongxia Ge et al. PROSTATE
- Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop
- (2011) Geun Taek Lee et al. PROSTATE
- Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes
- (2011) A. Aparicio et al. Cancer Discovery
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)
- (2010) Maria J Schymura et al. BMC CANCER
- HIF-1α Partners with FoxA2, a Neuroendocrine-Specific Transcription Factor, to Promote Tumorigenesis
- (2010) T.S. Karin Eisinger-Mathason et al. CANCER CELL
- Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors
- (2010) Jianfei Qi et al. CANCER CELL
- TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate☆
- (2010) Charles C. Guo et al. HUMAN PATHOLOGY
- Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells
- (2010) Pinar Uysal-Onganer et al. Molecular Cancer
- Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model
- (2010) X Yu et al. ONCOGENE
- Small Cell Carcinoma of the Prostate
- (2009) Wenle Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model
- (2009) Srinivas Nandana et al. PROSTATE
- Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
- (2009) Ganesh S. Palapattu et al. PROSTATE
- Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression
- (2008) X. Deng et al. CANCER RESEARCH
- The Nuclear Factor- B Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth
- (2008) R. J. Jin et al. CANCER RESEARCH
- Delta-Like 1 (Dlk-1), a Novel Marker of Prostate Basal and Candidate Epithelial Stem Cells, Is Downregulated by Notch Signalling in Intermediate/Transit Amplifying Cells of the Human Prostate
- (2008) Jens A. Ceder et al. EUROPEAN UROLOGY
- CaV3.2 T-type Calcium Channels Are Involved in Calcium-dependent Secretion of Neuroendocrine Prostate Cancer Cells
- (2008) Florian Gackière et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human ASH1 expression in prostate cancer with neuroendocrine differentiation
- (2008) Ida Rapa et al. MODERN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now